Cite
Stephenson D, Hill D, Cedarbaum JM, et al. The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's Disease. J Parkinsons Dis. 2019;9(4):825doi: 10.3233/JPD-199003.
Stephenson, D., Hill, D., Cedarbaum, J. M., Tome, M., Vamvakas, S., Romero, K., Conrado, D. J., Dexter, D. T., Seibyl, J., Jennings, D., Nicholas, T., Matthews, D., Xie, Z., Imam, S., Maguire, P., Russell, D., Gordon, M. F., Stebbins, G. T., Somer, E., Gallagher, J., Roach, A., Basseches, P., Grosset, D., Marek, K. (2019). The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's Disease. Journal of Parkinson's disease, 9(4), 825. https://doi.org/10.3233/JPD-199003
Stephenson, Diane, et al. "The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's Disease." Journal of Parkinson's disease vol. 9,4 (2019): 825. doi: https://doi.org/10.3233/JPD-199003
Stephenson D, Hill D, Cedarbaum JM, Tome M, Vamvakas S, Romero K, Conrado DJ, Dexter DT, Seibyl J, Jennings D, Nicholas T, Matthews D, Xie Z, Imam S, Maguire P, Russell D, Gordon MF, Stebbins GT, Somer E, Gallagher J, Roach A, Basseches P, Grosset D, Marek K. The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's Disease. J Parkinsons Dis. 2019;9(4):825. doi: 10.3233/JPD-199003. PMID: 31524182; PMCID: PMC6878913.
Copy
Download .nbib
